Monday, 26th September 2022
- 10:00 Start of Registration
- 11:30 – 12:30: YOU Event – Meet-up for Young Scientists (Hall 3)
- 13:00 – 13:15: Opening
- 13:15 – 13:45: Keynote lecture: Susanna Louhimies (European Commission) “Directive 2010/63/EU – Accelerating the transition towards less animals and better science” (Hall 1), Chairs: Winfried Neuhaus & Horst Spielmann
- 14:00 – 15:30: Scientific sessions in Hall 1, Hall 2, Hall 3
Hall 1 – HS 1 (ground floor): Covid-19 pandemic and the 3Rs
Chairs: Merel Ritskes-Hoitinga & Dilyana Filipova
14:00 – 14:20: Merel Ritskes-Hoitinga: “Never waste a good crisis: Case study revealed faster regulatory approval of COVID-19 vaccine with fewer animal studies and more alternatives. Let’s continue this promising road.”
14:20 – 14:40: Stefan Hippenstiel: “Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages”
14:40 – 15:00: Stefanie Dichtl: “Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections”
15:00 – 15:15: Viktoria Zaderer: “Optimizing animal-free 3D lung model for SARS-CoV-2 research and drug testing”
15:15 – 15:30: Dilyana Filipova: “Role of non-animal technologies in COVID-19 research”
Hall 2 – HS 2 (ground floor): NAMs for Developmental Neurotoxicity sponsored by
Chairs: Ellen Fritsche & Martin Paparella
14:00 – 14:20: Martin Paparella: “An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for non-animal-methods approaches”
14:20 – 14:40: Ellen Fritsche: “Human Test Methods for Developmental Neurotoxicity (DNT) Evaluation: Set-up, Scientific Validation and Statistical Analyses”
14:40 – 15:00: Iris Mangas: “Lessons Learned from EFSA AOP informed IATA Case Studies Integrating in vitro data for DNT Risk Assessment”
15:00 – 15:15: Katharina Koch: “An in-vitro approach to assess endocrine modes of action leading to developmental neurotoxicity”
15:15 – 15:30: David Pamies: “Human IPSC-Derived Model to Study Myelin Disruption”
Hall 3 – Seminar room (first floor): Preregistration/Best Practise
Chairs: Arti Ahluwalia & Györgyi Szabó
14:00 – 14:20: Jan Lauwereyns: “Tracking the Validity of Animal Models for Biomedical Research”
14:20 – 14:40: Lisa Grohmann: “Sharepoint Refinement: Internal platform for improved Refinement implementation”
14:40 – 15:00: Julia M. L. Menon: “Preregistration of animal research protocols: insights into preclinicals.eu 3-years development” – YSTA
15:00 – 15:15: Céline Heinl: “Preregistration in animal research – Animal welfare and scientific progress”
15:15 – 15:30: Sabine J. Bischoff: “Increase the quality of animal research with CIRS-LAS – Research before the study, report during the study and discuss after the study”
- 15:30 – 16:00: Coffee break
- 16:00 – 17:30: Scientific sessions in Hall 1, Hall 2, Hall 3
Hall 1 – HS 1 (ground floor): 3Rs Policy
Chairs: Susanna Louhimies & Horst Spielmann
16:00 – 16:20: Sandra Coecke: “How Food Science, Next Generation Life Science Methods and Artificial Intelligence relates to European regulatory decision-making on food systems for sustainable health?”
16:20 – 16:40: Laurence Walder: “Improving Member States reporting on the implementation of Directive 2010/63/EU”
16:40 – 17:00: Samantha Saunders: “The RAT list: a tool for highlighting areas of animal use ready for replacement”
17:00 – 17:15: Mathieu Vinken: “The European ONTOX project: safer chemicals using less animals”
17:15 – 17:30: Susanna Louhimies: “Education and training – an integral part of the Three Rs’ toolbox”
Hall 2 – HS 2 (ground floor): Novel Technologies
Chairs: Nathalie Jung & Jordi Grifols Ronda
16:00 – 16:20: Philipp Paulitschke: “New non-invasive, label-free monitoring approach for high cell culture and assay quality”
16:20 – 16:40: Nathalie Jung: “Enabling non-invasive and chemically-selective analysis of organoid cultures using confocal Raman microscopy”
16:40 – 17:00: Nicole Guazzelli: “Integrated Strategies for the Design of Core-Shell Structures as Advanced Barrier Models” – YSTA
17:00 – 17:15: Sebastian Eggert: “cellasys #8: A microphysiometric test to identify serum-free cell culture media”
17:15 – 17:30: Katrin Colleselli: “An optogenetic approach to characterise human TLR2 homo, -and heterodimers in THP-1 and THP-1 derived macrophages” – YSTA
Hall 3 – Seminar room (first floor): Refinement
Chairs: Adrian Smith & Annemarie Lang
16:00 – 16:20: Adrian Smith: “An overview of guidelines for better preclinical research”
16:20 – 16:40: Giuseppe Chirico: “An in-vivo engineered chip as a smart intravital multiphoton imaging window for new validation protocols of biomaterials”
16:40 – 17:00: Kerstin E. Auer: “Effect of group size and cage cleaning interval on male aggression level and wellbeing in two mouse strains
17:00 – 17:15: Angelique Wolter: “Evaluation of a new microparticulate depot formulation of buprenorphine for sustained post-surgical analgesia” – YSTA
17:15 – 17:30: Jürgen Alphonsus: “Development of 3D-printed surgical guides to standardize, refine and reduce animal experiments in osseointegration research (The ‘PRECISE’ project)”
- 18:00 – 19:00: Round table/panel discussion: “The rise and role of 3Rs centres in Europe” (Hall 1 – HS1 ground floor)
- 19:00 – 21:00: Welcome Reception (Aula)
- 20:00 – 21:00: YOU Event – Meet the Mentor (Hall 3 – Seminar room first floor)
Tuesday, 27th September 2022
- 9:00 – 9:30: Keynote lecture: Merel Ritskes-Hoitinga (University of Utrecht, NL) “Evidence-based transition to animal-free innovations: let’s make it happen!” (Hall 1), Chairs: Kristina Wagner & Doris Wilflingseder
- 9:40 – 11:10: Scientific sessions in Hall 1, Hall 2, Hall 3
Hall 1 – HS 1 (ground floor): 3Rs Policy: Accelerating the Transition to Innovation without the Use of Animals
Chairs: Kristina Wagner & Doris Wilflingseder
09:40 – 10:00: Luísa F. Bastos: “Transition to non-animal science – Current state of play in the EU”
10:00 – 10:20: Ingrid J. Visseren-Hamakers: “Accelerating the transition to animal-free innovation: A transformative governance approach”
10:20 – 10:40: Iris Mangas: “Implementing New Approach Methodologies in EFSA’s Next Generation Risk Assessment”
10:40 – 10:55: Evangelos Daskalopoulos: “Innovative models in biomedical research”
10:55 – 11:10: Lisa Hara Levin: “Outcomes from a Multistakeholder Engagement to Address the Challenges Associated with the Development, Regulatory Approval, and Implementation of Non-Animal Methods in Safety Testing and Biomedical Research”
Hall 2 – HS 2 (ground floor): Replacement: Lung in vitro Models
Chairs: Claus-Michael Lehr & Stefan Hippenstiel
09:40 – 10:00: Pauline Zamprogno: “IPF-on-chip: An alternative to animal models” – YSTA
10:00 – 10:20: Léa Todeschini: “A barrier-on-chip model with integrated 3D stretching to support preclinical decision making”
10:20 – 10:40: Michelle Mueller: “Human induced pluripotent stem cell-derived alveolar epithelial cells: a comparative gene and protein expression analysis between 2D- and 3D-differentiation”
10:40 – 10:55: Lorenz Latta: “AELVi “Arlo” – A novel monoclonal human alveolar epithelial cell line with reproducible barrier function”
10:55 – 11:10: Vanessa Almonti: “Evaluation of cytotoxicity and pro-inflammatory effects of Russian chrysotile fibres on the EpiAirway In Vitro Human Airway Model”
Hall 3 – Seminar room (first floor): NAMs for Risk Assessment
Chairs: Helena Kandarova & Kristin Schirmer
09:40 – 10:00: Jan Markus: “Development of physiologically relevant in vitro inhalation model to predict acute respiratory toxicity of mists and volatile liquids”
10:00 – 10:20: CANCELLED Caroline Frädrich: “Identifying endocrine disruptors via a HTS platform based on the Sandell-Kolthoff reaction”
10:20 – 10:40: Kristin Schirmer: “Fish cell lines as animal-free and resource-efficient alternatives to fish in environmental risk assessment”
10:40 – 10:55: Ignacio J. Tripodi: “Turning AOPS into testable hypotheses with natural language processing and tissue-specific knowledge graphs”
10:55 – 11:10: Mieke Van Mulders: “RE-Place: stimulating knowledge sharing on New Approach Methodologies via an open access database in Belgium”
- 11:10 – 11:40: Coffee break
- 11:40 – 13:10: Scientific sessions in Hall 1, Hall 2, Hall 3
Hall 1 – HS 1 (ground floor): 3Rs Centers – International
Chairs: Winfried Neuhaus & Yasuyuki Sakai
11:40 – 12:00: Winfried Neuhaus: “Updates of the EU3Rnet”
12:00 – 12:20: Yasuyuki Sakai: “Latest activities of JSAAE and Asian organization”
12:20 – 12:40: Stefan Hippenstiel: “Einstein Center 3R – a joint initiative of Berlin research institutions”
12:40 – 12:55: Arti Ahluwalia: “The challenges and successes of promoting 3Rs in teaching and research in Italy: a Centro 3R update”
12:55 – 13:10: Birgit Reininger-Gutmann: “A3RC – Austrian 3R Center Update”
Hall 2 – HS 2 (ground floor): Cancer Models
Chairs: Giuseppe Chirico & Anna Sebestyén
11:40 – 12:00: Michael J. Ausserlechner: “3D bioprinted, vascularized neuroblastoma microenvironment for studying tumor-angiogenesis and metastatic processes in fluidic chip devices”
12:00 – 12:20: Tine Haesen: “Ex Vivo Human Precision-Cut (Tumor) Lung Slices as a Tool for the Evaluation of CD109 in Non-Small-Cell Lung Cancer”
12:20 – 12:40: Yuval Daskal: “An Automated Platform for Creating Patient-Derived Glioblastoma Organoids and High Throughput Drug Screening” – YSTA
12:40 – 12:55: Djenana Vejzovic: “Short and long term patient-derived sarcoma models – to study the variety of soft-tissue tumors”
12:55 – 13:10: Beate Rinner: “Protein Arginine Methylation as a therapeutic Target on patient derived autologous Clear Cell Sarcoma Model”
Hall 3 – Seminar room (first floor): Ecotoxicolgy
Chairs: Christopher Faßbender & Stefan Scholz
11:40 – 12:00: Stefan Scholz: “A Bayesian Network tool for Predicting Fish Acute Toxicity – can simple behaviour tests in fish embryos used to increase confidence in predicted effect concentrations?”
12:00 – 12:20: Cinta Porte: “Development of fish liver PLHC-1 spheroids and its applicability to investigate the toxicity of plastic additives”
12:20 – 12:40: Julia Nöth: “Screening of vascular disruptors as an endpoint to predict developmental toxicity using zebrafish embryos”
12:40 – 12:55: Inska Reichstein: “Application of a Biotechnological Metabolisation System to Improve the Forecast Power of the Fish Embryo Acute Toxicity Test (FET)”
12:55 – 13:10: Kerstin Schirmer: “Using machine learning to predict chemical toxicity”
- 13:10 – 14:00: Lunchtime including Business lunch sponsored by RepRefRed
- 14:00 – 15:30: Poster session 1 (first floor)
- 15:30 – 17:00: Scientific sessions in Hall 1, Hall 2, Hall 3
Hall 1 – HS 1 (ground floor): Stem Cell Models
Chairs: Jürgen Hescheler & Bettina Seeger
15:30 – 15:50: Elodie Vandenhaute: “Bridging the gap between in vitro & in vivo testing: 3D cell culture taking into account the extracellular matrix”
15:50 – 16:10: Kristina Bartmann: “Assessment of human neuronal network formation and function using 2D and 3D hiPSC-derived cell systems”
16:10 – 16:30: Lisa Nguyen: “Puromycin aminonucleoside induces kidney injury in iPSC-derived kidney organoids”
16:30 – 16:45: Jördis Klose: “Phenomics and transcriptomics applied for key event identification resulting in an AOP network for developmental neurotoxicity”
16:45 – 17:00: Bettina Seeger: “High sensitivity of stem cell-derived motor neurons to pharmaceutically relevant Botulinum Neurotoxins A1, B1, E1 and F1”
17:00 – 17:15: Julia Kapr: “In vitro disease modeling of the Cockayne Syndrome B neuropathology using patient-derived iPSC – a 3R implementation approach” – YSTA
Hall 2 – HS 2 (ground floor): In silico Toxicology sponsored by
Chairs: Arti Ahluwalia & Ashwani Sharma
15:30 – 15:50: Arti Ahluwalia: “In silico methods: empowering and mainstreaming alternative methods”
15:50 – 16:10: Ashwani Sharma: “Machine learning based drug-induced Genotoxicity prediction model by evaluating physiochemical descriptors: Artificial Intelligence (AI) Approach”
16:10 – 16:30: Pedro Matos-Filipe: “Building virtual cohorts via the integration of public data”
16:30 – 16:45: Elena Lo Piparo: “Increasing confidence in NAMs through the integration of in silico and in vitro data: Pyrrolizidine Alkaloid (PA) case study”
16:45 – 17:00: Ermes Botte: “Advanced in silico approaches for designing human-relevant organ models” – YSTA
17:00 – 17:15: Vijay K. Gombar: “OrbiTox – Interactive Visualization of Multi-domain Experimental and Predicted Data for Translational Discovery”
Hall 3 – Seminar room (first floor): Liver & Intestine Models
Chairs: Gabriele Scholz & Armin Wolf
15:30 – 15:50: Armin Wolf: “The human 3D liver spheroid model is a pragmatic DILI hazard identification approach for early drug discovery phases”
15:50 – 16:10: Tim Kaden: “Evaluation of drug-induced liver toxicity of trovafloxacin and levofloxacin in a human microphysiological liver model” – YSTA
16:10 – 16:30: Valerie Beneke: “Microbiota dependent modulation of immune mediators in intestinal tissue slices ex vivo”
16:30 – 16:45: Brigitta Loretz: “Leaky Gut Model for the Investigation of Productive Delivery of JAK-1 siRNA”
16:45 – 17:00: Nathalie Jung: “Tuning tissue characteristics and complexity in in vitro models of the human intestinal mucosa”
17:00 – 17:15: Sabrina Schnur: “In vitro assay-based drug efficacy testing for the treatment of Inflammatory Bowel Disease (IBD)”
- 17:15 – 17:45: Coffee break
- 17:45 – 19:15: Prof. Horst Spielmann Session, Hall 1 – HS 1 (ground floor)
Chair: Winfried Neuhaus
Introduction
Horst Spielmann: “Pluripotent stem cell assays: modalities and applications for predictive embryotoxicity”
Jürgen Hescheler: “The application of the stem cell concept in basic and applied research in the life sciences”
Ellen Fritsche: “Horst Spielmann’s foster child: the human DNT in vitro tests”
Helena Kandarova: “Difficult roads often lead to beautiful destinations – lessons learnt at ZEBET”
Malte Spielmann: “The contribution of single cell technologies to the 3Rs”
- 20:00 – 24.00: Gala dinner in Neues Rathaus
Wednesday, 28th September 2022
- 9:00 – 9:30: Keynote lecture: Sasha Mendjan (IMBA, AUT) “Cardioids unravel human heart development and defects” (Hall 1), Chairs: Martin Paparella & Markéta Dvořáková
- 9:40 – 11:10: Scientific sessions in Hall 1, Hall 2, Hall 3
Hall 1 – HS 1 (ground floor): Non-animal Methods for Cardiac Toxicity
Chairs: Martin Paparella & Ronette Gehring
09:40 – 10:00: Martin Paparella: “Towards an Integrated Approach to Testing and Assessment for cardiotoxicity”
10:00 – 10:20: Monica Boffito: “Designing 3D bioengineered in vitro cardiac tissue models as reliable tools for the evaluation of chemical cardiotoxicity”
10:20 – 10:40: Edoardo Luca Viganò: “Computational modelling for cardiac toxicity”
10:40 – 10:55: Ronette Gehring: “The role of physiologically-based kinetic models within the new approach methodologies framework for predicting cardiotoxicity”
10:55 – 11:10: Mohammad Ghosheh: “The Electro-Mitochondrial Coupling of a Microphysiological Human Heart” – YSTA
Hall 2 – HS 2 (ground floor): Biological Barrier Models for Infection Studies
Chairs: Claus-Michael Lehr & Jens Kurreck
09:40 – 10:00: Claus-Michael Lehr: “Modelling Biological Barriers for Improving the Delivery of Novel Anti-infectives”
10:00 – 10:20: Jana Wächter: “A novel three-dimensional in vitro biofilm model in combination with human tissues – towards predictive chronic infection modeling” – YSTA
10:20 – 10:40: Jens Kurreck: “Bioprinting of Organ Models for Infection Studies”
10:40 – 10:55: Samy Aliyazdi: “3D-(Bio-) Printing for Advanced in Vitro Systems to Investigate Nano-Antibiotics against Bacterial Infections”
10:55 – 11:10: Mareike Ahrends: “Effect of CDE in RSV-infected human lung tissue ex vivo as alternative for animal-free testing of antiviral therapeutics”
Hall 3 – Seminar room (first floor): 3Rs and Education
Chairs: Christa Thoene-Reineke & David Pamies
09:40 – 10:00: Nick D. Jukes: “‘DVM: Training the Animal Doctor’ – a documentary film series”
10:00 – 10:20: Julia Menon: “Young TPI: the Dutch initiative for empowering the new scientific generation to go animal-testing-free” – YSTA
10:20 – 10:40: Lea Benner: ” “Improve your Skills” – the innovative 3R-Skills Lab of the 3R-Centre Giessen”
10:40 – 10:55: David Pamies: “Promoting 3Rs Public Awareness in a Young Audience”
10:55 – 11:10: Maximilian Nuber: “Modeling the In Utero Electroporation and surgical techniques beyond for the Replacement of animals in teaching”
- 11:10 – 11:40: Coffee break
- 11:40 – 13:10: Scientific sessions in Hall 1, Hall 2, Hall 3
Hall 1 – HS 1 (ground floor): Replacement – 3D in vitro Models sponsored by
Chairs: Winfried Neuhaus & Horst Spielmann
11:40 – 12:00: Glauco R. Souza: “Magnetic 3D Bioprinting as a Surrogate to Aorta Ring Assay”
12:00 – 12:20: Dongwei Wu: “3D bioprinted cancer model as an efficiently applicable drug testing platform” – YSTA
12:20 – 12:40: Antonella Cecchettini: “A dynamic in-vitro model of smooth muscle and endothelial cells cultures for vascular calcification study”
12:40 – 12:55: Moritz Pfeiffenberger: “Development of an innovative cartridge bioreactor for parallelized cultivation and stimulation of complex tissue models”
12:55 – 13:10: Tobias Weigel: “3D multi-layered epithelial models based on animal free fibrous scaffolds”
Hall 2 – HS 2 (ground floor): Replacement of Animal-derived Products
Chairs: Christopher Faßbender & Jan van der Valk
11:40 – 12:00: Tilo Weber: “Animals in the (Petri) Dish: Towards a Truly Animal-free Laboratory”
12:00 – 12:20: Manuela Cassotta: “A worldwide survey on the use of animal-derived materials and reagents in scientific experimentation”
12:20 – 12:40: Andreas Schiwy: “Animal-free in vitro – Replacement of animal-derived products within the OECD TG 487 and 455 – Phase 1 report”
12:40 – 12:55: Johannes Hackethal: “Perspectives and Challenges by use of Human Placenta derived Biomaterials in Cell Culture and Regenerative Medicine”
12:55 – 13:10: Barbara Jozef: “A serum-free medium that supports cultivation of fish cell lines: case study about RTgill-W1 going serum-free” – EPAA Student grantee
Hall 3 – Seminar room (first floor): 3Rs Centres and Implementation
Chairs: Kristina Kejlová & Arti Ahluwalia
11:40 – 12:00: Markéta Dvořáková: “3Rs Centre Czech Republic at National Institute of Public Health in Prague”
12:00 – 12:20: Karin Schmelz: “Evaluation of Charité 3R measures to implement 3Rs in biomedical research at Charité using online surveys and personal interviews”
12:20 – 12:40: Melissa K. Valussi: “3R-SMART: Schooling Platform for Methodological Approaches to Reduce Animal Tests”
12:40 – 12:55: Mieke Van Mulders: “The Innovation Center for 3Rs (IC-3Rs) in Belgium”
12:55 – 13:10: Sara Capdevila: “Implementation of the 3Rs program in the Comparative Medicine and Bioimage Centre of Catalonia.”
- 13:10 – 14:00: Lunchtime including Business lunch sponsored by BioTechne
- 14:00 – 15:30: Poster session 2 (first floor)
- 15:30 – 17:00: Scientific sessions in Hall 1, Hall 2, Hall 3
Hall 1 – HS 1 (ground floor): Skin and Eye in vitro Models
Chairs: Silvia Letasiova & Kristina Wagner
15:30 – 15:50: Franciska Erdő: “Comparative analysis of chemical composition and permeability properties of artificial and excised skins – Reduction and Replacement”
15:50 – 16:10: Marek Puskar: “An epidermal model containing melanocytes for skin pigmentation and lightening studies.”
16:10 – 16:30: Tommaso Sbrana: “A new highly representative in-vitro model of human skin”
16:30 – 16:45: Silvia Letasiova: “Identification and Sub-categorization of Ocular Irritants Using the EpiOcular Tissue Model – Prediction Models for Liquids and Solids”
16:45 – 17:00: Nicola Knetzger: “Impedance Spectroscopy as tool to determine concentration-dependent eye irritation effects”
Hall 2 – HS 2 (ground floor): 3Rs Projects: Quality Aspects and Funding
Chairs: Anna Maria Bassi & Rebecca Ram
15:30 – 15:50: Maren Hülsemann: “Quality enhancing measures in organ model research”
15:50 – 16:10: Jens Kurreck: “Animal Components in Life Sciences and their Alternatives”
16:10 – 16:30: Melanie-Jasmin Ort: “The relevance of human primary material in animal free research – orthopedic trauma as an example”
16:30 – 16:45: Rebecca Ram: “Lush Prize 2012- 2022 and beyond: Supporting human relevant, animal-free research”
16:45 – 17:00: Herwig Grimm: “Advancing 3Rs: The National Research Programme 79 of the Swiss National Science Foundation”
Hall 3 – Seminar room (first floor): Human Disease Models
Chairs: Paula Braun & Christian Lotz
15:30 – 15:50: Christian Lotz: “Focus on efficacy: In vitro tissue models for preclinical research”
15:50 – 16:10: Eva I. Reihs: “Bioengineering the inflammatory and degradative cross talk environment in arthritic diseases with patient-derived heterotypic joint-on-a-chip systems” – YSTA
16:10 – 16:30: Michael J Burgum: “Developing new-approach in vitro toxicology methods to elucidate the DNA damage mechanisms of nanofibres”
16:30 – 16:45: Lilas Courtot: “The Future of Parkinson’s Disease Research: A New Paradigm of Human-Specific Investigation Is Necessary”
16:45 – 17:00: Dilyana Filipova: “No improvement in 60 years: drug failure rates from the 1960s to the 2010s”
- 17:15 – 18:30: YSTA Awards/Announcement WC12/Farewell
